DNM1L and gastric cancer: Next, the results of multifactorial COX regression showed that higher DNM1L expression (HR = 2.420, 95% CI: 1.460–4.020, P = 0.001), T3 and T4 staging (HR = 3.580, 95% CI: 1.810–7.070, P < 0.001), and M1 stage (HR = 8.230, 95% CI: 4.080–16.580, P < 0.001) remained significantly associated with poor prognosis in patients with GC, and higher DNM1L expression level was an independent prognostic biomarker for patients with GC (Figure 3D).